<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is a thrombotic disorder in which the clinical features are venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and recurrent fetal loss </plain></SENT>
<SENT sid="1" pm="."><plain>We describe the case of a 39-year-old woman affected by <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> anterior <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> complicated by cardiogenic shock </plain></SENT>
<SENT sid="2" pm="."><plain>The patient, after the failure of thrombolysis, was successfully treated by rescue angioplasty </plain></SENT>
<SENT sid="3" pm="."><plain>The persistent <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> of these patients may lead to safety problems in thrombolytic treatment; therefore, primary angioplasty may be considered the treatment of choice </plain></SENT>
</text></document>